Edition:
United States

ValiRx PLC (VALX.L)

VALX.L on London Stock Exchange

0.93GBp
17 Nov 2017
Change (% chg)

-- (--)
Prev Close
0.93
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,985,140
52-wk High
7.24
52-wk Low
0.90

Chart for

About

ValiRx plc is a biopharmaceutical company. The principal activity of the Company is the development of oncology therapeutics and companion diagnostics. It focuses on the treatment of cancer and associated biomarkers, specializing in epigenomic and genetic analysis. It operates in two business segments: drug development and the... (more)
No analyst recommendations are available for .

Overall

Beta: 1.45
Market Cap(Mil.): £2.04
Shares Outstanding(Mil.): 203.96
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 185.06 15.80
EPS (TTM): -- -- --
ROI: -- -10.84 12.07
ROE: -- -39.67 16.02

Earnings vs. Estimates